|
|
Vol. 11.23 – 16 June, 2022
|
|
|
|
|
|
|
|
Scientists showed that Prevotella melaninogenica enhanced protection against Streptococcus pneumoniae, resulting in rapid pathogen clearance from the lung and improved survival in a mouse lung co-infection model. [Nature Communications]
|
|
|
|
|
|
PUBLICATIONSRanked by the impact factor of the journal
|
|
|
|
|
|
Cell compatibility, uptake, and intracellular trafficking were characterized in the murine alveolar macrophage cell line MH-S and the human bronchial epithelial cell line BEAS-2B in vitro.
[Small]
|
|
|
|
|
|
Investigators identified that signal transducer and activators of transduction 6 (STAT6) acted as a critical regulator of epithelium ferroptosis during acute lung injury.
[Cell Death & Disease]
|
|
|
|
|
|
Researchers generated lung bud organoids derived from human embryonic stem cells to study the interaction of Streptococcus pneumoniae with the alveolar epithelium.
[Microbiology Spectrum]
|
|
|
|
|
|
To examine the overall effect of STC1 on metabolism, scientists conducted a comprehensive metabolomics analysis to screen the overall metabolic changes induced by STC1 in an alveolar epithelial cell line.
[American Journal of Respiratory Cell and Molecular Biology]
|
|
|
|
|
|
Using Sendai virus to model natural infection in mice, investigators found evidence that alveolar type 1 cells had an intermediary role by persisting in areas depleted of alveolar type 2 cells, upregulating interferon responsive genes, and receding from invading airway cells.
[American Journal of Respiratory Cell and Molecular Biology]
|
|
|
|
|
|
Researchers evaluated the pharmacological activity of the ethanol extract of Veronica persica in an airway inflammation model. [Biomedicine & Pharmacotherapy]
|
|
|
|
|
|
The authors investigated the mechanisms underlying the action of interleukin-6 neutralizing antibodies in attenuating airway mucus hypersecretion in COPD. [Biomedicine & Pharmacotherapy]
|
|
|
|
|
|
Investigators assessed for changes in abundance and distribution of hemidesmosome-associated proteins following diacetyl (DA) exposure that contributed to DA-induced epithelial toxicity. [Scientific Reports]
|
|
|
|
|
|
|
|
In an unbiased functional genetic screen for radiosensitization targets in lung cancer, scientists identified syntaxin 18, a protein involved in retrograde vesicular transport between the Golgi apparatus and endoplasmic reticulum, as mediator of radioresistance.
[Cell Death & Disease]
|
|
|
|
|
|
Researchers reported monolayer cancer cell models wherein the human NSCLC cell line H2228 and pancreatic cancer cell line AsPC-1 could be reversibly induced to a quiescent state under hypoxic and serum-starved conditions. [Scientific Reports]
|
|
|
|
|
|
Scientists identified unique metabolite-related gene signatures specific for lung adenocarcinoma and lung squamous cell carcinoma and key pathways aberrantly regulated at both transcriptional and metabolic levels.
[Cancer Medicine]
|
|
|
|
|
|
The functions of semaphorin 4B in lung adenocarcinoma cells were investigated by in vitro experiments, including CCK-8 and plate clone formation. [BMC Cancer]
|
|
|
|
|
|
|
|
Investigators discuss changes in cell populations and gene expression, highlighting potential common features, such as alveolar cell epithelial injury and aberrant repair and monocyte-derived macrophage populations. [Human Genomics]
|
|
|
|
|
|
|
|
Galecto, Inc. announced that the first patient has been enrolled in the Phase IIa GALLANT-1 trial. GALLANT-1 was designed to study the combination of GB1211, Galecto’s oral small molecule galectin-3 inhibitor, with Roche’s PD-L1 checkpoint inhibitor, atezolizumab, for the first-line treatment of NSCLC. [Galecto, Inc.]
|
|
|
|
|
|
|
|
December 8 – 10, 2022 Los Angeles, California, United States
|
|
|
|
|
|
|
|
|
|
|
Washington University School of Medicine – St. Louis, Missouri, United States
|
|
|
|
|
|
|
University of Vermont – Burlington, Vermont, United States
|
|
|
|
|
|
|
University of Pittsburgh School of Medicine – Pittsburgh, Pennsylvania, United States
|
|
|
|
|
|
|
Temple University – Philadelphia, Pennsylvania, United States
|
|
|
|
|
|
|
German Cancer Research Center in the Helmholtz Association – Heidelberg, Germany
|
|
|
|
|
|